OPTOVERA is a workplace safety solution that uses patented technology to detect impairment risk on-the-job due to fatigue, medications, drugs like marijuana and opioids, alcohol, and any impairing neurological condition. The system analyzes users’ pupillary responses to a light stimulus using a testing device that comprises an opaque enclosure containing a smartphone. It's important to note that OPTOVERA does not identify the specific cause of impairment.

OPTOVERA technology uses a testing device, comprising of an opaque enclosure containing a smartphone, to analyze pupillary responses. This assessment, known as Pupillometry, is also utilized in critical care, medical research, and various clinical settings to detect neurological conditions resulting from various factors like injuries, illnesses, drugs, or medications.

The OPTOVERA solution consists of a cloud-based platform and testing devices comprising a Plastic Enclosure containing a preconfigured and locked smartphone. OPTOVERA provides the complete testing device.

OPTOVERA is a self-test. Users simply position the testing device over their eyes and listen to spoken instruction.

The self-test takes just one minute, and the results are displayed on the device screen and sent to the cloud-based platform, where they can be monitored and analyzed.

It is recommended that the individuals taking the test stand with their backs facing a dark area, such as a wall.

Only authorized personnel can access the individual test results of all enrolled users through the cloud-based dashboard.

Yes, the OPTOVERA technology is patented. It is protected by US Patent numbers 9,888,845 and 10,070,787.